Cold & Cough Remedies - Worldwide

  • Worldwide
  • In 2024, the revenue in the Cold & Cough Remedies market market worldwide amounts to US$42.65bn.
  • This market is expected to experience an annual growth rate of 6.18% (CAGR 2024-2029).
  • When comparing the revenue generated globally, the in the United States leads with US$11,190.00m in 2024.
  • Looking at the per person revenues in relation to the total population figures, an average of US$5.51 is generated per person in 2024.
  • Worldwide, the demand for cold and cough remedies is steadily increasing as consumers prioritize self-care and seek immediate relief from symptoms.

Key regions: United States, Japan, Australia, United Kingdom, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies market in Worldwide is experiencing significant growth due to various factors such as changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.

Customer preferences:
Customers worldwide are increasingly seeking remedies for cold and cough symptoms due to the rising awareness about health and wellness. The demand for natural and herbal remedies has been on the rise as customers are becoming more conscious of the potential side effects of traditional medicines. Additionally, customers are also looking for convenience and ease of use in cold and cough remedies, leading to the popularity of products such as cough syrups, lozenges, and throat sprays.

Trends in the market:
One of the major trends in the Cold & Cough Remedies market worldwide is the growing popularity of immune-boosting products. With the increasing focus on preventive healthcare, customers are looking for products that can strengthen their immune system and reduce the chances of catching a cold or cough. This has led to the emergence of a wide range of immune-boosting supplements, herbal teas, and natural remedies that claim to enhance the body's natural defense mechanisms.Another trend in the market is the rising demand for combination products that offer relief from multiple symptoms. Customers are looking for cold and cough remedies that can address not only cough and congestion but also other associated symptoms such as sore throat, headache, and body aches. This has led to the development of products that combine different active ingredients to provide comprehensive relief.

Local special circumstances:
In different countries and regions, there are unique circumstances that influence the Cold & Cough Remedies market. For example, in countries with colder climates, there is often a higher demand for cold and cough remedies due to the increased prevalence of respiratory illnesses. Additionally, cultural factors also play a role in shaping customer preferences. For example, in some Asian countries, traditional herbal remedies are highly valued and widely used for treating cold and cough symptoms.

Underlying macroeconomic factors:
The Cold & Cough Remedies market in Worldwide is also influenced by underlying macroeconomic factors. Factors such as GDP growth, disposable income levels, and healthcare expenditure play a significant role in determining the demand for healthcare products, including cold and cough remedies. In countries with a growing middle class and increasing healthcare spending, the market for cold and cough remedies is likely to experience robust growth.In conclusion, the Cold & Cough Remedies market in Worldwide is witnessing growth due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customers are increasingly seeking natural and convenient remedies, while trends such as immune-boosting products and combination remedies are gaining popularity. Local factors and macroeconomic conditions also contribute to the growth of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)